v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flow from operating activities:    
Net loss $ (8,454) $ (7,637)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 171 194
Stock-based compensation expense 769 592
Issuance of common stock to vendor 409 253
Right-of-use asset amortization 182 201
(Loss) / gain on foreign currency transactions (2,374) 283
Change in fair value of the warrant liability   (672)
Change in operating assets and liabilities:    
Accounts receivable   269
Research and development tax credit receivable 148 (499)
Prepaid expenses and other assets (186) 43
Other non-current assets   1
Accounts payable and accrued expenses 2,984 149
Lease liabilities (145) (166)
Other current liabilities 175 (20)
Net cash used in operating activities (6,321) (7,009)
Cash flows from investing activities:    
Purchases of property, plant and equipment (105) (75)
Net cash used by investing activities (105) (75)
Cash flow from financing activities:    
Proceeds from the exercise of warrants   3
Net cash provided by financing activities   3
Effect of exchange rate changes on cash 166 28
Net change in cash (6,260) (7,053)
Cash, beginning of period 7,141 8,836
Cash, end of period 881 1,783
Supplemental disclosure of cash and non-cash investing and financing activities    
Issuance of common shares for consulting services 409 253
Right-of-use asset and lease liability additions $ 706 $ 82

Source

HTML PDF
ZIP